Breast Cancer Markers: Case Study

Froggy Jumps

Parties jouées 98

Créer une copie

À propos de cette activité

Marker-driven therapy decisions

Créé par

LAVANYA BALAN

India

Téléchargez la version pour jouer sur papier

Top 10 résultats

#	Jeux	Précision	temps
1	LAVANYA BALAN 10 Mars 2026	% 100	00:52

Voulez-vous apparaître dans le Top 10 de ce jeu? Connectez-vous pour vous identifier.

Créez votre propre jeu gratuite à partir de notre créateur de jeu

Affrontez vos amis pour voir qui obtient le meilleur score dans ce jeu

Créer un défi

pizza

Lorelay Tyana

Romania

(274)

joc despre pizza
Bill of Rights Game - The Constitutionalist

Doni The Don

United States

(92)

Test your knowledge on the Bill of Rights. A fun way to test your knowledge and focus on where you need to improve.
Phlebotomy Order of Draw Quiz

Pamela Chapman

United States

(61)

Test your knowledge of the order of draw in Phlebotomy with these 10 questions!
Ethos, Pathos, and Logos Quiz

Kristine Vester

United States

(135)

Test your knowledge of ethos, pathos, and logos with these 10 questions on examples of persuasive techniques.
The Integumentary System

Breanna Nesbitt

United States

(59)

Functions and Structures of the skin

		%
	Anonyme	%
		%
		%

Imprimez votre jeu

Breast Cancer Markers: Case Study


Froggy Jumps Breast Cancer Markers: Case StudyVersion en ligne Marker-driven therapy decisions par LAVANYA BALAN 1 What cellular marker would be most useful to guide systemic therapy in breast carcinoma patient? a Ki-67 proliferation index b Estrogen receptor (ER) status c HER2/neu status 2 If the tumor is ER-positive, which therapy is commonly used? a Chemotherapy alone b Radiation therapy c Endocrine therapy with tamoxifen or aromatase inhibitors 3 Which test determines hormone receptor status in breast cancer? a Flow cytometry for CD44 b DNA sequencing for BRCA c Immunohistochemistry for ER and PR 4 Which marker's amplification guides the use of trastuzumab? a ER/PR b Ki-67 c HER2/neu 5 Which marker indicates high proliferative activity and can influence prognosis? a HER2 status b ER status c Ki-67 proliferation index 6 Which receptor status must be positive to consider endocrine therapy in this patient? a Triple-negative status b HER2 positivity c Estrogen receptor (ER) positivity 7 Triple-negative breast cancer is defined by the absence of which markers? a ER and PR only b ER, PR, and HER2 c HER2 and ER only 8 What subtype is defined by invasion from the carcinoma breaching the basement membrane into surrounding tissue? a Invasive ductal carcinoma b Ductal carcinoma in situ c Lobular carcinoma in situ 9 Which marker is studied when a patient's first degree relative has breast carcinoma ? a Ki-67 proliferation index b HER2 status c BRCA mutation status 10 What targeted therapy is specifically used for HER2-positive tumors? a Tamoxifen b Trastuzumab c Aromatase inhibitors 11 What targeted therapy is specifically used for HER2-positive tumors? a Tamoxifen b Trastuzumab c Aromatase inhibitors 12 indian file pattern is seen in which carcinoma a lobular carcinoma b invasive breast carcinoma NOS c mucinous carcinoma 13 Carcinoma with with dilated ducts and central zone of necrosis a colloid carcinoma b ductal carcinoma insitu comedo carcinoma type c tubular carcinoma 14 All mutations are seen in breast carcinoma except a BRCA1, BRCA2 b Tp53, PTEN c NF1,NF2 15 molecular subtypes of breast carcinoma are all except a Luminal A, Luminal B b HER2 positive, Triple negative c Luminal C

Vous pouvez intégrer le jeu dans un LMS compatible avec LTI 1.1 ou LTI 1.3 comme Canvas, Moodle ou Blackboard. Les scores seront ainsi automatiquement enregistrés dans le carnet de notes de la plateforme.

Breast Cancer Markers: Case Study

Froggy Jumps

À propos de cette activité

Créé par

Téléchargez la version pour jouer sur papier

Top Jeux

Froggy Jumps

pizza

Froggy Jumps

Bill of Rights Game - The Constitutionalist

Froggy Jumps

Phlebotomy Order of Draw Quiz

Froggy Jumps

Ethos, Pathos, and Logos Quiz

Froggy Jumps

The Integumentary System

Froggy Jumps

Breast Cancer Markers: Case StudyVersion en ligne

par LAVANYA BALAN

What cellular marker would be most useful to guide systemic therapy in breast carcinoma patient?

If the tumor is ER-positive, which therapy is commonly used?

Which test determines hormone receptor status in breast cancer?

Which marker's amplification guides the use of trastuzumab?

Which marker indicates high proliferative activity and can influence prognosis?

Which receptor status must be positive to consider endocrine therapy in this patient?

Triple-negative breast cancer is defined by the absence of which markers?

What subtype is defined by invasion from the carcinoma breaching the basement membrane into surrounding tissue?

Which marker is studied when a patient's first degree relative has breast carcinoma ?

What targeted therapy is specifically used for HER2-positive tumors?

What targeted therapy is specifically used for HER2-positive tumors?

indian file pattern is seen in which carcinoma

Carcinoma with with dilated ducts and central zone of necrosis

All mutations are seen in breast carcinoma except

molecular subtypes of breast carcinoma are all except